Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN)

Trubion Pharmaceuticals, Inc. (NASDAQ: TRBN), a biopharmaceutical company, focuses its efforts on creating a pipeline of innovative protein therapeutic product candidates designed to treat autoimmune and inflammatory diseases and cancer. The company aims to develop an assortment of first-in-class and best-in-class products, customized for optimal safety, efficacy, and convenience. Trubion’s product development efforts are focused on three technology pillars that encompass the expanded foundation for Trubion product development. For further information, visit the Company’s web site at www.trubion.com.